Sentien Biotechnologies, Inc. awarded NIH Phase II SBIR Award for Kidney Program
Filter: PRESS RELEASES IN THE NEWS EVENTS
Sentien Biotechnologies, Inc. awarded NIH Phase II SBIR Award for Kidney Program
This Phase II SBIR grant advances pre-clinical work of Sentien’s lead kidney injury program into large animal testing.